Category Press Releases

WuXi Biologics

WuXi Biologics Achieves ISO 22301 Certification and Expands ISO/IEC 27001 Compliance

WuXi Biologics Achieves ISO 22301 Certification and Expands ISO/IEC 27001 Compliance WuXi Biologics (“WuXi Bio”) (2269.HK), a globally recognized Contract Research, Development, and Manufacturing Organization (CRDMO), has announced a significant milestone in its ongoing commitment to operational resilience and information…

Read MoreWuXi Biologics Achieves ISO 22301 Certification and Expands ISO/IEC 27001 Compliance
Halozyme

Halozyme Announces Positive CHMP Opinion for Bristol Myers Squibb’s Subcutaneous Opdivo® with ENHANZE

Halozyme Announces Positive CHMP Opinion for Bristol Myers Squibb’s Subcutaneous Opdivo® with ENHANZE Halozyme Therapeutics, Inc. (NASDAQ: HALO) recently announced a significant milestone in oncology treatment development, as Bristol Myers Squibb has received a positive opinion from the Committee for…

Read MoreHalozyme Announces Positive CHMP Opinion for Bristol Myers Squibb’s Subcutaneous Opdivo® with ENHANZE
Sensydia

ACC 2025 Sensydia CPS™ Accurately Assesses Mean Pulmonary Artery Pressure Non-Invasively

ACC 2025 Sensydia CPS™ Accurately Assesses Mean Pulmonary Artery Pressure Non-Invasively Sensydia, a clinical-stage company specializing in non-invasive cardiac assessment technologies, has announced promising results from a recent clinical study evaluating its AI-powered Cardiac Performance System (CPS™). These findings were…

Read MoreACC 2025 Sensydia CPS™ Accurately Assesses Mean Pulmonary Artery Pressure Non-Invasively
Equillium

Equillium Announces Q4 & Full-Year 2024 Results, Corporate & Clinical Updates

Equillium Announces Q4 & Full-Year 2024 Results, Corporate & Clinical Updates Equillium, Inc., a clinical-stage biotechnology company specializing in immunobiology, has reported its financial results for the fourth quarter and full year 2024, alongside recent corporate and clinical developments. The…

Read MoreEquillium Announces Q4 & Full-Year 2024 Results, Corporate & Clinical Updates